New Hampshire Code of Administrative Rules
He - Department of Health and Human Services
Subtitle He-A - Former Office of Alcohol and Drug Abuse Prevention
Chapter He-A 300 - CERTIFICATION AND OPERATION OF ALCOHOL AND OTHER DRUG DISORDER TREATMENT PROGRAMS
Part He-A 304 - CERTIFICATION AND OPERATIONAL REQUIREMENTS FOR OPIOID TREATMENT PROGRAMS
Section He-A 304.27 - Discontinuance of Methadone/Buprenorphine
Current through Register No. 40, October 3, 2024
(a) At the time of admission and every 6 months thereafter, the OTP shall provide each client with a written protocol to request discontinuance of methadone/buprenorphine treatment, including but not limited to:
(b) An individual methadone/buprenorphine discontinuance plan shall be developed and implemented for all clients who request discontinuance.
(c) The determination to voluntarily discontinue methadone/buprenorphine shall be left to the judgment of the client, in consultation with staff.
(d) If staff do not agree with the client's decision to discontinue methadone/buprenorphine, the staff shall document such disagreement in the client's record.
(e) Reduction of a client's methadone/buprenorphine dosage shall:
(f) In situations where staff have determined that onsite discontinuance is undesirable, such as due to the client's aggressive behavior:
(g) OTPs shall have procedures to modify a client's discontinuance protocol or to engage the client in withdrawal management or maintenance services in the event that a client relapses during discontinuance.
(h) Continued services and supports necessary to support the client through and for up to 90 days after the discontinuance process shall be provided by the OTP in consultation with the clinical staff.
(i) OTPs shall have discharge policies as required by He-A 304.28.